Bjoern Schwander (Björn Schwander)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Health Insurance

Metabolic Syndrome

Top Venues

PharmacoEconomics

ClinicoEconomics and outcomes research : CEOR

Journal of robotic surgery

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Bjoern Schwander, Katharina Klesper, Siegbert Rossol, Ken Herrmann, York Francis Zoellner
Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Bjoern Schwander, Katharina Klesper, Siegbert Rossol, Ken Herrmann, York Francis Zoellner
Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Bjoern Schwander, Klaus Kaier, Mickaël J C Hiligsmann, Silvia M A A Evers, Mark Nuijten
Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity. PharmacoEconomics 40 (9) (2022)
Bjoern Schwander, Mark Nuijten, Silvia M A A Evers, Mickaël J C Hiligsmann
Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success. PharmacoEconomics 39 (4) (2021)
Ali Ghomi, William Nolan, Derrick J Sanderson, Rohnn Sanderson, Bjoern Schwander, Josh Feldstein
Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform? Journal of robotic surgery (2021)
Bjoern Schwander, Mark Nuijten, Mickaël J C Hiligsmann, Silvia M A A Evers
Event simulation and external validation applied in published health economic models for obesity: a systematic review. Expert review of pharmacoeconomics & outcomes research 18 (5) (2018)